Download
https://www.ndtvprofit.com/business/fda-woes-hit-aurobindo-pharma-as-unit-4-gets-nine-observations?utm_source=telegram&utm_medium=referral&utm_campaign=socialshare
Majority of the U.S. FDA’s observations For Aurobindo Pharma’s Unit 4 are relating to equipment and cleanliness.
Share